X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline - Takeaways - MDSpire

X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline

  • By

  • Dalal S Ali

  • Thomas O Carpenter

  • Erik A Imel

  • Leanne M Ward

  • Natasha M Appelman-Dijkstra

  • Catherine Chaussain

  • Suzanne M Jan de Beur

  • Pablo Florenzano

  • Hajar Abu Alrob

  • Rana Aldabagh

  • R Todd Alexander

  • Farah Alsarraf

  • Signe Sparre Beck-Nielsen

  • Martin Biosse-Duplan

  • Rachel K Crowley

  • Karel Dandurand

  • Guido Filler

  • Lisa Friedlander

  • Seiji Fukumoto

  • Claudia Gagnon

  • Paul Goodyer

  • Corinna Grasemann

  • Chelsey Grimbly

  • Salma Hussein

  • Muhammad K Javaid

  • Sarah Khan

  • Aneal Khan

  • Anna Lehman

  • Willem F Lems

  • E Michael Lewiecki

  • Ciara McDonnell

  • Reza D Mirza

  • Emmett Morgante

  • Archibald Morrison

  • Anthony A Portale

  • Christina Rao

  • Yumie Rhee

  • Eric T Rush

  • Heide Siggelkow

  • Sotirios Tetradis

  • Laura Tosi

  • Gordon Guyatt

  • Maria Luisa Brandi

  • Aliya A Khan

  • February 17, 2025

  • 0 min

Share

  • 1

    An International Working Group developed new guidelines for diagnosing and managing X-linked hypophosphatemia (XLH) in pediatric patients.

  • 2

    The guidelines are based on systematic reviews comparing burosumab to conventional therapies and assessing patient-important outcomes.

  • 3

    Diagnosis of XLH is confirmed by chronic hypophosphatemia and an X-linked inheritance pattern, with specific clinical features noted.

  • 4

    Monitoring recommendations were derived from expert surveys and rated as weak due to very low certainty of evidence.

  • 5

    The guidelines address dental complications in XLH and propose strategies to mitigate these issues for affected children.

Original Source(s)

X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline

  • by Dalal S Ali, Thomas O Carpenter, Erik A Imel, Leanne M Ward, Natasha M Appelman-Dijkstra, Catherine Chaussain, Suzanne M Jan de Beur, Pablo Florenzano, Hajar Abu Alrob, Rana Aldabagh, R Todd Alexander, Farah Alsarraf, Signe Sparre Beck-Nielsen, Martin Biosse-Duplan, Rachel K Crowley, Karel Dandurand, Guido Filler, Lisa Friedlander, Seiji Fukumoto, Claudia Gagnon, Paul Goodyer, Corinna Grasemann, Chelsey Grimbly, Salma Hussein, Muhammad K Javaid, Sarah Khan, Aneal Khan, Anna Lehman, Willem F Lems, E Michael Lewiecki, Ciara McDonnell, Reza D Mirza, Emmett Morgante, Archibald Morrison, Anthony A Portale, Christina Rao, Yumie Rhee, Eric T Rush, Heide Siggelkow, Sotirios Tetradis, Laura Tosi, Gordon Guyatt, Maria Luisa Brandi, Aliya A Khan

  • February 17, 2025

Related Content

Women Overdue for Cancer Screenings

More than 80% of women who were partially up to date reported a wellness visit in the prior year, suggesting missed opportunities for screening engagement in primary care.

Secular trends in HbA1c levels among children and adolescents with type 1 diabetes

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?